|
|
Volumn 41, Issue 1, 2003, Pages 1-2
|
|
Pharmacoeconomics and the "4th hurdle" Drug reimbursement policies in Central and Eastern Europe
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
BUDGET;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG QUALITY;
DRUG SAFETY;
DRUG SCREENING;
EASTERN EUROPE;
ECONOMIC ASPECT;
EDITORIAL;
EUROPE;
EUROPEAN UNION;
EVIDENCE BASED MEDICINE;
HEALTH CARE ACCESS;
HEALTH CARE FINANCING;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH MAINTENANCE ORGANIZATION;
HOSPITAL BILLING;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL LITERATURE;
PATIENT ATTITUDE;
PHARMACOECONOMICS;
PRESCRIPTION;
REIMBURSEMENT;
RISK BENEFIT ANALYSIS;
|
|
EID: 0037233981
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: 10.5414/CPP41001 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
